Healthcare
Waterland-backed Atos buys Fleetinsel Klinik Hamburg
Physicians from the clinic will receive shares in the business, amounting to a minority position
Khosla, Seventure in $20m Eligo round
Series-A also includes a $2m award from the Worldwide Innovation Challenge
Born2Grow leads series-A for Venneos
Seed investors HTGF, the Max Planck Society and private investors also take part
Nextech, Syncona in $80m Autolus series-C
Company, launched just three years ago, has now raised a total of $150m
LBO France et al. lead Bioserenity's €15m series-A
French fund managers Idinvest Partners and BPI France also take part in the funding round
HTGF backs Numaferm
European Investment Fund also invested in the round alongside various business angels
HTGF co-leads €3m seed round for Atriva
Stichting Participatie Atriva co-leads the round, with VC firm InSynchrony Ventures also taking part
Hadean Ventures to close first fund on target
GP will invest in the healthcare sector across Europe, with particular focus on the Nordics
ArchiMed hits €315m hard-cap for Med II fund
New fund is more than double the size of its predecessor and closed after four months on the road
PE-backed Ameos buys Seeklinik Brunnen
Ameos will invest in the expansion of the clinic's facilities over the next four years
Cambridge Innovation et al. in $26m series-A for CMR
Latest funding round brings total invested in medical robotics company to $46m
Corpfin's Palex bolts on Taper and Cymit
Bolt-ons will expand the medical devices company's headcount beyond 400 across numerous locations
Ardian-backed Ionisos buys Stermed
Acquisition strengthens Ionisos's technological platform and expands its geographic footprint
Balderton leads $30m series-D for Sophia Genetics
360 Capital Partners and existing investors Invoke Capital and Alychio also take part in the round
Sofinnova leads €11m fundraising for DNA Script
French investor now has 10 portfolio companies in the industrial biotechnology sector
Life Sciences Partners leads €31.7m series-A for Immunic
LSP led the round, which initially closed on €17.5m in 2016, with Omega and Fund+ joining
Deal in Focus: Forbion et al. sell Rigontec to MSD for up to €464m
MSD may make additional payments of up to €349m, equating to a maximum transaction value of €464m
Alta Life Sciences leads €4.2m series-A for Peptomyc
Deal is the first investment for the Spanish GP, which manages the Alta Life Science Spain I fund
HTGF in €8m series-B for Amal Therapeutics
Round was co-led by corporate venture players Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn
Magnum sells Orliman to strategic investor
Following a two-year investment period, the GP has fully exited the asset via trade sale
Bain, Cinven yield to Elliott's Stada share price demands
Elliott announced last week that it would not support the Stada bid for less than €74.4 per share
Portobello buys five dental clinics
Following a €500m first close, the GP completes the first investment from its fourth fund
Charme invests in Livingbridge-backed Witherslack
Vendor will reinvest for a significant minority stake in the specialist education and care provider
Turkven to float Medical Park after three-year holding
GP is likely to float the Turkish hospital group on the Istanbul stock exchange in Q1 2018